ZOLINZA (vorinostat) for Cutaneous T-cell Lymphoma - Cancer Therapy Advisor

ZOLINZA (vorinostat) for Cutaneous T-cell Lymphoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for ZOLINZA (vorinostat), indicated for cutaneous T-cell lymphoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 8: Use in Specific Populations
Slide 11: Clinical Pharmacology
Slide 15: Warnings and Precautions
Slide 21: Clinical Safety and Efficacy
Slide 27: Drug Storage and Supply
Slide 30: References

Next hm-slideshow in Lymphoma